Annual Report

Overview

The report describes GSK India's FY 2022-23 pharmaceutical portfolio and the Shingrix launch, reports company environmental performance including 108,441.19 GJ of total energy and 46% renewable energy, and states a net-zero-impact target for 2030. Its Principle 6 energy, water, waste, and emissions disclosures received limited independent assurance from DNV.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: Ends 31 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services